Nova Patents
AT199261T

Hybrid immunoglobulins

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

47 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
44062589United States of AmericaA
9006849United States of AmericaW

Members47

Family members, oldest first
DocumentOfficeKind
CA2072642A1CanadaA1
WO9108298A2World Intellectual Property Organization (WIPO)A2
WO9108298A3World Intellectual Property Organization (WIPO)A3
US5098833AUnited States of AmericaA
US5116964AUnited States of AmericaA
EP0526452A1European Patent Office (EPO)A1
JPH05503009AJapanA
US5216131AUnited States of AmericaA
US5225538AUnited States of AmericaA
US5428130AUnited States of AmericaA
US5455165AUnited States of AmericaA
US5514582AUnited States of AmericaA
US5714147AUnited States of AmericaA
US5840844AUnited States of AmericaA
HK1013298A1Hong Kong, ChinaA1
EP1029870A2European Patent Office (EPO)A2
EP1029870A3European Patent Office (EPO)A3
EP0526452B1European Patent Office (EPO)B1
AT199261TThis recordAustriaT
ATE199261T1AustriaT1
DE69033705D1GermanyD1
HK1030222A1Hong Kong, ChinaA1
ES2155819T3SpainT3
DK0526452T3DenmarkT3
DE69033705T2GermanyT2
GR3035856T3GreeceT3
US6406697B1United States of AmericaB1
CA2072642CCanadaC
JP2002325589AJapanA
US2003143220A1United States of AmericaA1
US2006229435A1United States of AmericaA1
EP0526452B2European Patent Office (EPO)B2
DK0526452T4DenmarkT4
DE69033705T3GermanyT3
ES2155819T5SpainT5
EP1029870B1European Patent Office (EPO)B1
AT396735TAustriaT
ATE396735T1AustriaT1
DE69034253D1GermanyD1
EP1970386A2European Patent Office (EPO)A2
DK1029870T3DenmarkT3
ES2308826T3SpainT3
LU91498I2LuxembourgI2
NL300372I1Netherlands (Kingdom of the)I1
DE122008000063I1GermanyI1
EP1970386A8European Patent Office (EPO)A8
DE122008000063I2GermanyI2